Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders

J Alzheimers Dis. 2004 Dec;6(6 Suppl):S19-25. doi: 10.3233/jad-2004-6s601.
No abstract available

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Brain-Derived Neurotrophic Factor / drug effects
  • CREB-Binding Protein
  • Cell Proliferation / drug effects*
  • Depression / drug therapy
  • Depression / physiopathology
  • Diet
  • Feeding Behavior / physiology
  • Hippocampus / drug effects
  • Hippocampus / pathology
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / pathology
  • Neurodegenerative Diseases / physiopathology*
  • Neurons / drug effects*
  • Neurons / pathology
  • Neurons / physiology
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use*
  • Nitric Oxide / pharmacology*
  • Nitric Oxide / therapeutic use*
  • Nitroso Compounds / pharmacology
  • Nitroso Compounds / therapeutic use
  • Nuclear Proteins / drug effects
  • Rats
  • Trans-Activators / drug effects

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Neuroprotective Agents
  • Nitroso Compounds
  • Nuclear Proteins
  • Trans-Activators
  • 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
  • Nitric Oxide
  • CREB-Binding Protein
  • Crebbp protein, rat